Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
about
The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and ReproducibilityEvidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinomaThe changing landscape of gynaecological cancer diagnosis: implications for histopathological practice in the 21st century.Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer.Prognostic significance of overexpression of p53 in uterine endometrioid adenocarcinomas with an analysis of nuclear grade.Expression of p53 protein in high-grade gastroenteropancreatic neuroendocrine carcinoma.The evolution of endometrial carcinoma classification through application of immunohistochemistry and molecular diagnostics: past, present and future.Blinded histopathological characterisation of POLE exonuclease domain-mutant endometrial cancers: sheep in wolf's clothing.p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.IMP3 distinguishes uterine serous carcinoma from endometrial endometrioid adenocarcinoma.
P2860
Q37068930-6007001E-68B8-46D4-97E0-D823D71E2D21Q37113497-D212372E-832C-4AD0-AA82-4FD23A7CD2A8Q39037647-A1624A44-BC9C-4019-B979-C21D53316441Q40992668-9776AD09-17BC-4B6F-AC7E-EBEEEC0B46F3Q46311812-56D2E779-ADF8-4280-8C6E-AF45AB90E6B3Q46513952-74B8DEB5-EAB6-4B04-9F7E-7914D45CAB1BQ47299584-9FA00E99-7039-427C-8175-84D3CD125A81Q47970130-D0A9AB8F-7726-4AF7-97D1-A12E7EF0654CQ53061462-A1B92D09-4874-4A91-943D-D91C60937C72Q53470669-B06822EB-C8FD-4603-BED6-663793BC595C
P2860
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@en
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@nl
type
label
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@en
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@nl
prefLabel
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@en
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@nl
P2093
P2860
P1433
P1476
Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
@en
P2093
Christopher P Crum
George L Mutter
Kenneth R Lee
Lesley Lomo
Marisa R Nucci
Michelle S Hirsch
Ming-Chieh Lin
P2860
P2888
P304
P356
10.1038/MODPATHOL.2008.97
P577
2008-05-23T00:00:00Z